{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:57:42Z","timestamp":1791899862258,"version":"4.3.4"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002848","name":"Comisi\u00f3n Nacional de Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["AFB170005"],"award-info":[{"award-number":["AFB170005"]}],"id":[{"id":"10.13039\/501100002848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1190144"],"award-info":[{"award-number":["1190144"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["REDI 170462"],"award-info":[{"award-number":["REDI 170462"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["11181090"],"award-info":[{"award-number":["11181090"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Matrix Biology Plus"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.mbplus.2021.100059","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T15:20:41Z","timestamp":1615130441000},"page":"100059","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Driving fibrosis in neuromuscular diseases: Role and regulation of Connective tissue growth factor (CCN2\/CTGF)"],"prefix":"10.1016","volume":"11","author":[{"given":"Daniela L.","family":"Rebolledo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"Lipson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Brandan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mbplus.2021.100059_bb0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1172\/JCI93557","article-title":"Extracellular matrix as a driver of progressive fibrosis","volume":"128","author":"Herrera","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.mbplus.2021.100059_bb0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.mbplus.2021.100059_bb0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mus.22232","article-title":"Transforming growth factor-beta induces skeletal muscle atrophy and fibrosis through the induction of atrogin-1 and scleraxis","volume":"45","author":"Mendias","year":"2012","journal-title":"Muscle Nerve"},{"issue":"7","key":"10.1016\/j.mbplus.2021.100059_bb0020","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.bbadis.2013.02.007","article-title":"Tissue mechanics and fibrosis","volume":"1832","author":"Wells","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"17","key":"10.1016\/j.mbplus.2021.100059_bb0025","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1111\/febs.12278","article-title":"Role of proteoglycans in the regulation of the skeletal muscle fibrotic response","volume":"280","author":"Brandan","year":"2013","journal-title":"FEBS J."},{"issue":"2","key":"10.1016\/j.mbplus.2021.100059_bb0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12079-020-00553-8","article-title":"HIF-hypoxia signaling in skeletal muscle physiology and fibrosis","volume":"14","author":"Valle-Tenney","year":"2020","journal-title":"J Cell Commun Signal"},{"issue":"9","key":"10.1016\/j.mbplus.2021.100059_bb0035","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nm.1852","article-title":"PlGF-MMP-9-expressing cells restore microcirculation and efficacy of cell therapy in aged dystrophic muscle","volume":"14","author":"Gargioli","year":"2008","journal-title":"Nat. Med."},{"issue":"24","key":"10.1016\/j.mbplus.2021.100059_bb0040","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1093\/hmg\/ddt352","article-title":"Reducing CTGF\/CCN2 slows down mdx muscle dystrophy and improves cell therapy","volume":"22","author":"Morales","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mbplus.2021.100059_bb0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2044-5040-4-6","article-title":"Andrographolide attenuates skeletal muscle dystrophy in mdx mice and increases efficiency of cell therapy by reducing fibrosis","volume":"4","author":"Cabrera","year":"2014","journal-title":"Skelet. Muscle"},{"issue":"2","key":"10.1016\/j.mbplus.2021.100059_bb0050","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/jcp.21324","article-title":"Skeletal muscle cells express the profibrotic cytokine connective tissue growth factor (CTGF\/CCN2), which induces their dedifferentiation","volume":"215","author":"Vial","year":"2008","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.mbplus.2021.100059_bb0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/jb\/mvu056","article-title":"CCN family protein 2 (CCN2) promotes the early differentiation, but inhibits the terminal differentiation of skeletal myoblasts","volume":"157","author":"Nishida","year":"2015","journal-title":"J. Biochem."},{"issue":"6","key":"10.1016\/j.mbplus.2021.100059_bb0060","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.matbio.2006.04.004","article-title":"Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation","volume":"25","author":"Droguett","year":"2006","journal-title":"Matrix Biol."},{"issue":"6","key":"10.1016\/j.mbplus.2021.100059_bb0065","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.matbio.2013.03.007","article-title":"Role of skeletal muscle proteoglycans during myogenesis","volume":"32","author":"Brandan","year":"2013","journal-title":"Matrix Biol."},{"key":"10.1016\/j.mbplus.2021.100059_bb0070","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.matbio.2017.12.016","article-title":"Targeting TGF-beta signaling for the treatment of fibrosis","volume":"68-69","author":"Gyorfi","year":"2018","journal-title":"Matrix Biol."},{"issue":"1","key":"10.1016\/j.mbplus.2021.100059_bb0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2044-5040-1-19","article-title":"Role of TGF-beta signaling in inherited and acquired myopathies","volume":"1","author":"Burks","year":"2011","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.mbplus.2021.100059_bb0080","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.matbio.2018.03.007","article-title":"Connective tissue growth factor (CTGF) from basics to clinics","volume":"68-69","author":"Ramazani","year":"2018","journal-title":"Matrix Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.mbplus.2021.100059_bb0085","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1186\/1755-1536-5-S1-S24","article-title":"CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis","volume":"5","author":"Lipson","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"2","key":"10.1016\/j.mbplus.2021.100059_bb0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12079-009-0037-7","article-title":"Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease?","volume":"3","author":"Leask","year":"2009","journal-title":"J Cell Commun Signal"},{"key":"10.1016\/j.mbplus.2021.100059_bb0095","series-title":"Matricellular proteins of the Cyr61\/CTGF\/NOV (CCN) family and the nervous system, 9","author":"Malik","year":"2015"},{"issue":"1239","key":"10.1016\/j.mbplus.2021.100059_bb0100","article-title":"Connective tissue growth factor: from molecular understandings to drug discovery","volume":"8","author":"Chen","year":"2020","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"46","key":"10.1016\/j.mbplus.2021.100059_bb0105","doi-asserted-by":"crossref","first-page":"17953","DOI":"10.1074\/jbc.RA118.004559","article-title":"Connective tissue growth factor (CCN2) is a matricellular preproprotein controlled by proteolytic activation","volume":"293","author":"Kaasboll","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.mbplus.2021.100059_bb0110","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1167\/iovs.12-9425","article-title":"A connective tissue growth factor signaling receptor in corneal fibroblasts","volume":"53","author":"Blalock","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"24","key":"10.1016\/j.mbplus.2021.100059_bb0115","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1016\/j.febslet.2012.10.038","article-title":"CCN2\/CTGF binds to fibroblast growth factor receptor 2 and modulates its signaling","volume":"586","author":"Aoyama","year":"2012","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.mbplus.2021.100059_bb0120","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1681\/ASN.2003100905","article-title":"Connective tissue growth factor CCN2 interacts with and activates the tyrosine kinase receptor TrkA","volume":"16","author":"Wahab","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.mbplus.2021.100059_bb0125","doi-asserted-by":"crossref","first-page":"8848","DOI":"10.1074\/jbc.M313204200","article-title":"Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan","volume":"279","author":"Gao","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"27","key":"10.1016\/j.mbplus.2021.100059_bb0130","doi-asserted-by":"crossref","first-page":"24242","DOI":"10.1074\/jbc.M110.189365","article-title":"Decorin interacts with connective tissue growth factor (CTGF)\/CCN2 by LRR12 inhibiting its biological activity","volume":"286","author":"Vial","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.mbplus.2021.100059_bb0135","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.bbagen.2006.11.010","article-title":"Connective tissue growth factor binds to fibronectin through the type I repeat modules and enhances the affinity of fibronectin to fibrin","volume":"1770","author":"Yoshida","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.mbplus.2021.100059_bb0140","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ncb826","article-title":"Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta","volume":"4","author":"Abreu","year":"2002","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.mbplus.2021.100059_bb0145","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1096\/fj.01-0332fje","article-title":"Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis","volume":"16","author":"Inoki","year":"2002","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.mbplus.2021.100059_bb0150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2613.2010.00750.x","article-title":"Increased connective tissue growth factor associated with cardiac fibrosis in the mdx mouse model of dystrophic cardiomyopathy","volume":"92","author":"Au","year":"2011","journal-title":"Int. J. Exp. Pathol."},{"issue":"1\u20132","key":"10.1016\/j.mbplus.2021.100059_bb0155","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jns.2007.09.043","article-title":"Connective tissue growth factor is overexpressed in muscles of human muscular dystrophy","volume":"267","author":"Sun","year":"2008","journal-title":"J. Neurol. Sci."},{"issue":"8","key":"10.1016\/j.mbplus.2021.100059_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220665","article-title":"Cross-sectional study into age-related pathology of mouse models for limb girdle muscular dystrophy types 2D and 2F","volume":"14","author":"Verhaart","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.mbplus.2021.100059_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177649","article-title":"ALS skeletal muscle shows enhanced TGF-beta signaling, fibrosis and induction of fibro\/adipogenic progenitor markers","volume":"12","author":"Gonzalez","year":"2017","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.mbplus.2021.100059_bb0170","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1093\/hmg\/ddy204","article-title":"The inhibition of CTGF\/CCN2 activity improves muscle and locomotor function in a murine ALS model","volume":"27","author":"Gonzalez","year":"2018","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.mbplus.2021.100059_bb0175","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00401-003-0741-y","article-title":"Increased expression of connective tissue growth factor in amyotrophic lateral sclerosis human spinal cord","volume":"106","author":"Spliet","year":"2003","journal-title":"Acta Neuropathol (Berl)"},{"issue":"1","key":"10.1016\/j.mbplus.2021.100059_bb0180","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1620\/tjem.238.49","article-title":"Expression of TGF-beta1 and CTGF is associated with fibrosis of denervated sternocleidomastoid muscles in mice","volume":"238","author":"Liu","year":"2016","journal-title":"Tohoku J. Exp. Med."},{"issue":"2","key":"10.1016\/j.mbplus.2021.100059_bb0185","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1460-9568.2005.03855.x","article-title":"Denervation-induced alterations in gene expression in mouse skeletal muscle","volume":"21","author":"Magnusson","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.mbplus.2021.100059_bb0190","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.matbio.2019.01.002","article-title":"Denervation-induced skeletal muscle fibrosis is mediated by CTGF\/CCN2 independently of TGF-beta","volume":"82","author":"Rebolledo","year":"2019","journal-title":"Matrix Biol."},{"issue":"9","key":"10.1016\/j.mbplus.2021.100059_bb0195","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1517\/14728222.2013.812074","article-title":"CCN2: a novel, specific and valid target for anti-fibrotic drug intervention","volume":"17","author":"Leask","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"issue":"12","key":"10.1016\/j.mbplus.2021.100059_bb0200","first-page":"700","article-title":"Targeting CTGF","volume":"10","author":"Kok","year":"2014","journal-title":"EGF and PDGF pathways to prevent progression of kidney disease, Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.mbplus.2021.100059_bb0205","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1042\/CS20140264","article-title":"Cellular and molecular actions of CCN2\/CTGF and its role under physiological and pathological conditions","volume":"128","author":"Kubota","year":"2015","journal-title":"Clin Sci (Lond)"},{"issue":"8","key":"10.1016\/j.mbplus.2021.100059_bb0210","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.1007\/s12035-019-1490-9","article-title":"CTGF\/CCN2 from skeletal muscle to nervous system: impact on neurodegenerative diseases","volume":"56","author":"Gonzalez","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.mbplus.2021.100059_bb0215","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/978-1-4939-6430-7_43","article-title":"Analysis of pathological activities of CCN2\/CTGF in muscle dystrophy","volume":"1489","author":"Acu\u00f1a","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.mbplus.2021.100059_bb0220","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12079-017-0409-3","article-title":"The pro-fibrotic connective tissue growth factor (CTGF\/CCN2) correlates with the number of necrotic-regenerative foci in dystrophic muscle","volume":"12","author":"Morales","year":"2018","journal-title":"J Cell Commun Signal"},{"issue":"4","key":"10.1016\/j.mbplus.2021.100059_bb0225","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/path.2952","article-title":"CTGF\/CCN-2 over-expression can directly induce features of skeletal muscle dystrophy","volume":"225","author":"Morales","year":"2011","journal-title":"J. Pathol."},{"key":"10.1016\/j.mbplus.2021.100059_bb0230","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2044-5040-4-7","article-title":"Novel and optimized strategies for inducing fibrosis in vivo: focus on Duchenne Muscular Dystrophy","volume":"4","author":"Pessina","year":"2014","journal-title":"Skelet. Muscle"},{"issue":"1","key":"10.1016\/j.mbplus.2021.100059_bb0235","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00441-013-1642-6","article-title":"Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF\/CCN-2)","volume":"353","author":"Morales","year":"2013","journal-title":"Cell Tissue Res."},{"issue":"4","key":"10.1016\/j.mbplus.2021.100059_bb0240","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3892\/etm.2017.4105","article-title":"Expression levels of TGF-beta1 and CTGF are associated with the severity of Duchenne muscular dystrophy","volume":"13","author":"Song","year":"2017","journal-title":"Exp Ther Med"},{"issue":"1","key":"10.1016\/j.mbplus.2021.100059_bb0245","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1755-1536-4-4","article-title":"Cooperative interaction of CTGF and TGF-beta in animal models of fibrotic disease","volume":"4","author":"Wang","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.mbplus.2021.100059_bb0250","first-page":"1","article-title":"Force dependent effects of chronic overuse on fibrosis-related genes and proteins in skeletal muscles","author":"Hilliard","year":"2020","journal-title":"Connect. Tissue Res."},{"issue":"2","key":"10.1016\/j.mbplus.2021.100059_bb0255","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/ptj\/82.2.173","article-title":"Pathophysiological tissue changes associated with repetitive movement: a review of the evidence","volume":"82","author":"Barr","year":"2002","journal-title":"Phys. Ther."},{"issue":"5","key":"10.1016\/j.mbplus.2021.100059_bb0260","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.1096\/fj.202000240RR","article-title":"Blocking CTGF\/CCN2 reduces established skeletal muscle fibrosis in a rat model of overuse injury","volume":"34","author":"Barbe","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.mbplus.2021.100059_bb0265","series-title":"An Open-label, Single-arm Phase 2 Trial Evaluating Pamrevlumab, a Monoclonal Antibody to Connective Tissue Growth Factor (CTGF) in Non-ambulatory Subjects With Duchenne Muscular Dystrophy (NCT02606136), Parent Project Muscular Dystrophy Annual Meeting","author":"Lipson","year":"2019"},{"issue":"1","key":"10.1016\/j.mbplus.2021.100059_bb0270","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.4081\/bam.2014.1.5","article-title":"The biology of long-term denervated skeletal muscle","volume":"24","author":"Carlson","year":"2014","journal-title":"Eur J Transl Myol"},{"issue":"6","key":"10.1016\/j.mbplus.2021.100059_bb0275","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/mus.27059","article-title":"Fast repetitive stretch suppresses denervation-induced muscle fibrosis","volume":"62","author":"Tanaka","year":"2020","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.mbplus.2021.100059_bb0280","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cjtee.2019.02.001","article-title":"The mechanisms and treatments of muscular pathological changes in immobilization-induced joint contracture: a literature review","volume":"22","author":"Wang","year":"2019","journal-title":"Chin. J. Traumatol."},{"issue":"2","key":"10.1016\/j.mbplus.2021.100059_bb0285","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/bpa.12350","article-title":"The role of skeletal muscle in amyotrophic lateral sclerosis","volume":"26","author":"Loeffler","year":"2016","journal-title":"Brain Pathol."},{"issue":"2","key":"10.1016\/j.mbplus.2021.100059_bb0290","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/s12035-013-8578-4","article-title":"Amyotrophic lateral sclerosis and skeletal muscle: an update","volume":"49","author":"Pansarasa","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.mbplus.2021.100059_bb0295","series-title":"Spinal Muscle Atrophy","author":"Burr","year":"2020"},{"issue":"11","key":"10.1016\/j.mbplus.2021.100059_bb0300","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1002\/jor.24709","article-title":"Blocking CTGF\/CCN2 reverses neural fibrosis and sensorimotor declines in a rat model of overuse-induced median mononeuropathy","volume":"38","author":"Barbe","year":"2020","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.mbplus.2021.100059_bb0305","doi-asserted-by":"crossref","first-page":"104349","DOI":"10.1016\/j.neuint.2018.11.024","article-title":"Regenerating CNS myelin: emerging roles of regulatory T cells and CCN proteins","volume":"130","author":"de la Vega Gallardo","year":"2019","journal-title":"Neurochem. Int."},{"issue":"14","key":"10.1016\/j.mbplus.2021.100059_bb0310","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1096\/fj.05-4359fje","article-title":"Connective tissue growth factor (CTGF) expression in the brain is a downstream effector of insulin resistance- associated promotion of Alzheimer\u2019s disease beta-amyloid neuropathology","volume":"19","author":"Zhao","year":"2005","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.mbplus.2021.100059_bb0315","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/089771501750170930","article-title":"Differential cellular accumulation of connective tissue growth factor defines a subset of reactive astrocytes, invading fibroblasts, and endothelial cells following central nervous system injury in rats and humans","volume":"18","author":"Schwab","year":"2001","journal-title":"J. Neurotrauma"},{"issue":"7","key":"10.1016\/j.mbplus.2021.100059_bb0320","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fj.03-1273rev","article-title":"TGF-beta signaling and the fibrotic response","volume":"18","author":"Leask","year":"2004","journal-title":"FASEB J."},{"issue":"9","key":"10.1016\/j.mbplus.2021.100059_bb0325","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1172\/JCI43230","article-title":"CTGF directs fibroblast differentiation from human mesenchymal stem\/stromal cells and defines connective tissue healing in a rodent injury model","volume":"120","author":"Lee","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.mbplus.2021.100059_bb0330","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-beta: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"10.1016\/j.mbplus.2021.100059_bb0335","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/00002281-200211000-00009","article-title":"Pathogenesis of fibrosis: role of TGF-beta and CTGF","volume":"14","author":"Ihn","year":"2002","journal-title":"Curr. Opin. Rheumatol."},{"issue":"25","key":"10.1016\/j.mbplus.2021.100059_bb0340","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1093\/hmg\/ddu413","article-title":"Myofiber-specific inhibition of TGFbeta signaling protects skeletal muscle from injury and dystrophic disease in mice","volume":"23","author":"Accornero","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"19","key":"10.1016\/j.mbplus.2021.100059_bb0345","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.232157","article-title":"Cross-talk between TGF-beta and PDGFRalpha signaling pathways regulates the fate of stromal fibro-adipogenic progenitors","volume":"132","author":"Contreras","year":"2019","journal-title":"J. Cell Sci."},{"issue":"4","key":"10.1016\/j.mbplus.2021.100059_bb0350","doi-asserted-by":"crossref","first-page":"F707","DOI":"10.1152\/ajprenal.00007.2002","article-title":"TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells","volume":"283","author":"Gore-Hyer","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"10.1016\/j.mbplus.2021.100059_bb0355","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.1038\/s41598-018-25370-3","article-title":"Essential role of connective tissue growth factor (CTGF) in transforming growth factor-beta1 (TGF-beta1)-induced myofibroblast transdifferentiation from Graves\u2019 orbital fibroblasts","volume":"8","author":"Tsai","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mbplus.2021.100059_bb0360","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cyto.2017.09.002","article-title":"Connective tissue growth factor regulates transition of primary bronchial fibroblasts to myofibroblasts in asthmatic subjects","volume":"102","author":"Wojcik-Pszczola","year":"2018","journal-title":"Cytokine"},{"issue":"12","key":"10.1016\/j.mbplus.2021.100059_bb0365","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cellbi.2004.09.003","article-title":"Connective tissue growth factor regulates the key events in tubular epithelial to myofibroblast transition in vitro","volume":"28","author":"Zhang","year":"2004","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.mbplus.2021.100059_bb0370","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.matbio.2019.09.003","article-title":"Role of hypoxia in skeletal muscle fibrosis: synergism between hypoxia and TGF-beta signaling upregulates CCN2\/CTGF expression specifically in muscle fibers","volume":"87","author":"Valle-Tenney","year":"2020","journal-title":"Matrix Biol."},{"issue":"9","key":"10.1016\/j.mbplus.2021.100059_bb0375","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1002\/jcb.25982","article-title":"Hypoxia impairs muscle function and reduces myotube size in tissue engineered skeletal muscle","volume":"118","author":"Martin","year":"2017","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.mbplus.2021.100059_bb0380","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1096\/fj.201800622RR","article-title":"Genetic manipulation of CCN2\/CTGF unveils cell-specific ECM-remodeling effects in injured skeletal muscle","volume":"33","author":"Petrosino","year":"2019","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.mbplus.2021.100059_bb0385","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1159\/000080086","article-title":"Angiotensin II induces hypoxia-inducible factor-1 alpha in PC 12 cells through a posttranscriptional mechanism: role of AT2 receptors","volume":"24","author":"Wolf","year":"2004","journal-title":"Am. J. Nephrol."},{"issue":"1","key":"10.1016\/j.mbplus.2021.100059_bb0390","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1684\/ecn.2015.0360","article-title":"Role of endothelin-1 in the skin fibrosis of systemic sclerosis","volume":"26","author":"Jing","year":"2015","journal-title":"Eur. Cytokine Netw."},{"issue":"3","key":"10.1016\/j.mbplus.2021.100059_bb0395","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.yjmcc.2008.11.017","article-title":"Endothelin-1 induces connective tissue growth factor expression in cardiomyocytes","volume":"46","author":"Recchia","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.mbplus.2021.100059_bb0400","first-page":"298","article-title":"The endothelin A receptor mediates fibrocyte differentiation in chronic obstructive asthma","volume":"188","author":"Weng","year":"2013","journal-title":"The involvement of connective tissue growth factor, Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.mbplus.2021.100059_bb0405","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.bcp.2014.01.030","article-title":"Endothelin-1 induces connective tissue growth factor expression in human lung fibroblasts by ETAR-dependent JNK\/AP-1 pathway","volume":"88","author":"Weng","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.mbplus.2021.100059_bb0410","doi-asserted-by":"crossref","first-page":"7841","DOI":"10.1038\/s41598-017-08334-x","article-title":"Angiotensin II induces connective tissue growth factor expression in human hepatic stellate cells by a transforming growth factor beta-independent mechanism","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.mbplus.2021.100059_bb0415","doi-asserted-by":"crossref","DOI":"10.1177\/1470320318759358","article-title":"Connective tissue growth factor expression after angiotensin II exposure is dependent on transforming growth factor-beta signaling via the canonical Smad-dependent pathway in hypertensive induced myocardial fibrosis","volume":"19","author":"Wong","year":"2018","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"issue":"4","key":"10.1016\/j.mbplus.2021.100059_bb0420","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1582-4934.2011.01354.x","article-title":"Angiotensin II receptor type 1 blockade decreases CTGF\/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles","volume":"16","author":"Cabello-Verrugio","year":"2012","journal-title":"J. Cell. Mol. Med."},{"issue":"5","key":"10.1016\/j.mbplus.2021.100059_bb0425","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.tips.2015.03.001","article-title":"Angiotensins as therapeutic targets beyond heart disease","volume":"36","author":"Passos-Silva","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.mbplus.2021.100059_bb0430","doi-asserted-by":"crossref","unstructured":"M.J. Acu\u00f1a, E. Brandan, D. Motta-Santos, Skeletal Muscle System. Angiotensin-(1\u20137): A Comprehensive Review, Cham: Springer International Publishing. (2019) 169\u201390.","DOI":"10.1007\/978-3-030-22696-1_11"},{"issue":"5","key":"10.1016\/j.mbplus.2021.100059_bb0435","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/hmg\/ddt514","article-title":"Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-beta signalling","volume":"23","author":"Acu\u00f1a","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.mbplus.2021.100059_bb0440","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1006\/bbrc.1998.8983","article-title":"Effects of lysophosphatidic acid on proliferation of stellate cells and hepatocytes in culture","volume":"248","author":"Ikeda","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.mbplus.2021.100059_bb0445","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nm1685","article-title":"The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak","volume":"14","author":"Tager","year":"2008","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.mbplus.2021.100059_bb0450","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/01.mcg.0000225642.90898.0e","article-title":"Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C","volume":"41","author":"Watanabe","year":"2007","journal-title":"J. Clin. Gastroenterol."},{"issue":"12","key":"10.1016\/j.mbplus.2021.100059_bb0455","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.7150\/jca.41841","article-title":"Lysophosphatidic acid receptors: biochemical and clinical implications in different diseases","volume":"11","author":"Xiang","year":"2020","journal-title":"J. Cancer"},{"issue":"7","key":"10.1016\/j.mbplus.2021.100059_bb0460","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1194\/jlr.R046458","article-title":"LPA receptor signaling: pharmacology, physiology, and pathophysiology","volume":"55","author":"Yung","year":"2014","journal-title":"J. Lipid Res."},{"issue":"9","key":"10.1016\/j.mbplus.2021.100059_bb0465","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.bbalip.2008.06.005","article-title":"Two pathways for lysophosphatidic acid production","volume":"1781","author":"Aoki","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.mbplus.2021.100059_bb0470","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.yexcr.2014.11.020","article-title":"Lysophospholipid receptors in drug discovery","volume":"333","author":"Kihara","year":"2015","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.mbplus.2021.100059_bb0475","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cellsig.2010.10.019","article-title":"Connective tissue growth factor induction by lysophosphatidic acid requires transactivation of transforming growth factor type beta receptors and the JNK pathway","volume":"23","author":"Cabello-Verrugio","year":"2011","journal-title":"Cell. Signal."},{"issue":"4","key":"10.1016\/j.mbplus.2021.100059_bb0480","doi-asserted-by":"crossref","first-page":"C415","DOI":"10.1152\/ajpcell.00013.2017","article-title":"Expression of CTGF\/CCN2 in response to LPA is stimulated by fibrotic extracellular matrix via the integrin\/FAK axis","volume":"314","author":"Riquelme-Guzman","year":"2018","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.mbplus.2021.100059_bb0485","article-title":"The linkage between inflammation and fibrosis in muscular dystrophies: the axis ATX\/LPA\/LPARs as a new target?","author":"Gallardo","year":"2021","journal-title":"Matrix Biol"},{"key":"10.1016\/j.mbplus.2021.100059_bb0490","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.pharmtox.010909.105753","article-title":"LPA receptors: subtypes and biological actions","volume":"50","author":"Choi","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"2","key":"10.1016\/j.mbplus.2021.100059_bb0495","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.atherosclerosis.2004.04.011","article-title":"Induction of connective tissue growth factor (CTGF) in human endothelial cells by lysophosphatidic acid, sphingosine-1-phosphate, and platelets","volume":"175","author":"Muehlich","year":"2004","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.mbplus.2021.100059_bb0500","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cellsig.2005.05.011","article-title":"Differential involvement of the integrin-linked kinase (ILK) in RhoA-dependent rearrangement of F-actin fibers and induction of connective tissue growth factor (CTGF)","volume":"18","author":"Graness","year":"2006","journal-title":"Cell. Signal."},{"issue":"10","key":"10.1016\/j.mbplus.2021.100059_bb0505","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.cellsig.2010.03.020","article-title":"Linking cell structure to gene regulation: signaling events and expression controls on the model genes PAI-1 and CTGF","volume":"22","author":"Samarakoon","year":"2010","journal-title":"Cell. Signal."},{"issue":"2","key":"10.1016\/j.mbplus.2021.100059_bb0510","first-page":"75","article-title":"Hippo\/YAP pathway for targeted therapy","volume":"3","author":"Felley-Bosco","year":"2014","journal-title":"Transl Lung Cancer Res"},{"issue":"5","key":"10.1016\/j.mbplus.2021.100059_bb0515","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1096\/fj.12-219378","article-title":"LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation","volume":"27","author":"Sakai","year":"2013","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.mbplus.2021.100059_bb0520","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1038\/s41598-017-05624-2","article-title":"Inhibition of CTGF ameliorates peritoneal fibrosis through suppression of fibroblast and myofibroblast accumulation and angiogenesis","volume":"7","author":"Sakai","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mbplus.2021.100059_bb0525","doi-asserted-by":"crossref","unstructured":"S. Moon, S. Lee, J.A. Caesar, S. Pruchenko, A. Leask, J.A. Knowles, J. Sinon, B. Chaqour, A CTGF-YAP regulatory pathway is essential for angiogenesis and barriergenesis in the retina, iScience 23(6) (2020) 101184.","DOI":"10.1016\/j.isci.2020.101184"}],"container-title":["Matrix Biology Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259002852100003X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259002852100003X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:39:23Z","timestamp":1778906363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259002852100003X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":105,"alternative-id":["S259002852100003X"],"URL":"https:\/\/doi.org\/10.1016\/j.mbplus.2021.100059","relation":{},"ISSN":["2590-0285"],"issn-type":[{"value":"2590-0285","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Driving fibrosis in neuromuscular diseases: Role and regulation of Connective tissue growth factor (CCN2\/CTGF)","name":"articletitle","label":"Article Title"},{"value":"Matrix Biology Plus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mbplus.2021.100059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100059"}}